TapImmune Inc. (OTC:TPIV) shares rose 11.06% to $0.261 after the company announced that following FDA IND approval, it will sponsor a Phase I HER-2/neu targeted therapeutic vaccine trial in HER-2/neu positive breast cancer patients at the Mayo Clinic.
MediSwipe Inc (OTC:MWIP) soared 13.33% to $0.0068 after the Company planned to retire 26 million common shares to the company’s treasury; please note that MediSwipe is actually planning to retire 36 million common shares.
Micro Imaging Technology Inc (PINK:MMTC) surged 4.38% to $0.0143 with more than 36.50 million shares traded hands, compared to its average volume of 26.65 million shares. Micro Imaging Technology, Inc. is a development stage company. The Company is a holding company whose operations are conducted through its 81% owned subsidiary.
Pacific Gold Corp. (PINK:PCFG) added 4.83% to $0.0760 with more than 2.63 million shares traded hands, compared to its average volume of 4.72 million shares. Pacific Gold Corp. is engaged in the identification, acquisition, exploration and development of mining prospects that contain gold and/or tungsten mineralizations.
THERMA-MED INC (PINK:THRA) slumped 46.67% to $0.0008 with more than 132.67 million shares traded hands, compared to its average volume of 29.74 million shares. First Majestic Silver Corp. is committed to building a senior Silver producing mining company based on an aggressive development and acquisition plan with a focus on Mexico. The Company presently owns and operates three producing silver mines in Mexico; the La Parrilla Silver Mine, the San Martin Silver Mine and the La Encantada Silver Mine. Production from these three mines is anticipated to be over 7.5 million ounces of silver in 2011.
The assembled information distributed by epicstocknews.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Epicstocknews.com does expect that investors will buy and sell securities based on information assembled and presented herein. Epicstocknews.com will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial advisor.